Boron, a valuable underground mineral whose usage area is increasing day by day, has been identified as an essential trace element in plant development. However, research on its usage for humans and animals is still ongoing. Recommended doses are physiologically involved in many systems, but excess boron can be risky for living organisms and the environment. Boron moves in an endless cycle between air, water, soil, and food, and can accumulate. Concentration can rise too much, especially in areas with boron mines. This situation causes contamination in the environment and directly affects human, animal and plant health. There is a paucity of research on the residue status of boron mineral, which is extensively mined and frequently used in certain regions, notably Turkey. In our study, we sought to ascertain the effects of proximity to boron mines on boron concentration in blood, urine, water, and feed in animals. In the study, 60 (20*3) cattle living in areas 0–5, 5–15 and 15–30 km away from the boron mine site were used. Blood and urine samples were taken from cattle. Boron concentrations were determined by sampling the feed and water they consumed. The results of the analyses demonstrated that boron levels in all samples were influenced by the distance to the mine. A statistically significant decrease was observed, particularly in drinking water and blood boron levels. This situation is a major risk factor, especially for living organisms in proximity to boron and other mines. It is also recommended to establish more comprehensive studies investigating the effects of boron concentration on living organisms.
The aim of this study is to by converting albendazole and levamisole, which are antiparasitic drugs used in both humans and animals, into liposomal formulations under laboratory conditions. To ascertain the circumstance in practice, characterization studies were additionally conducted. The study was performed by modifying the hydration of the thin lipid film. Experiments were carried out with egg phosphatidylcholine, cholesterol, chloroform and methanol in different amounts. Albendazole and levamisole formulations were made with the substances used in liposomes. Zeta potential, polydispersity index, encapsulation efficiency, particle size measurements and scanning electron microscopy were performed as part of characterization studies. The results show that Lipo LVM has the smallest particle size value at 380.87 ± 19.52 nm, whereas Lipo LVM–PBS has the largest particle size value at 7236.67 ± 443.89 nm. Values for the polydispersity index fall between 0.527 and 0.896. Zeta potential levels, on the other hand, range from -7.6 mV to -46.8 mV. While this value was determined as -8.2 ± 0.4 mV in LD Lipo ABZ and -18.4 ± 0.6 mV in HD Lipo ABZ, respectively. Both HD Lipo ABZ and LD Lipo ABZ have polydispersity indices for ABZ of 0.529 ± 0.066 and 0.896 ± 0.085, respectively. It was found that the particle size rose as the desired amount of liposomal albendazole increased. It was found that the liposomization of albendazole was higher than that of levamisole. Albendazole and levamisole liposomal formulations were successfully developed in the investigation. By carrying out characterization studies, it was discovered that it may be employed in clinical trials. In the upcoming years, it is anticipated that continuous research in the field of nanotechnology will improve human and animal health and aid to more effectively control parasite infestations.
This study aimed to investigate the changes in Paraoxonase (PON), Carbonic Anhydrase (CA), and β-glucosidase levels of different aged rats and scopolamine-induced memory impairment rats. This study used young, adult, and middle-aged male Wistar Albino rats. Scopolamine was administered as a single dose/multiple doses and a Morris water maze (MWM) was used for spatial learning testing in rats. Enzyme-linked immunosorbent assays (ELISAs) were used to determine serum and liver PON and β-glucosidase levels. The CA enzyme activity was assayed following the hydration of CO2. As a result of the comparison of age-related and scopolamine-related changes in PON and β-glucosidase levels in liver and serum samples, no significant age-related and scopolamine-effective changes were observed in serum, while liver PON and liver β-glucosidase levels were found to change significantly. CA activity studies, on the other hand, showed that adults have the lowest CA activity compared to young and middle-aged groups and scopolamine inhibited CA activity in vivo. We found that adult rats modeled with memory impairment had statistically lower levels of liver PON and liver β-glucosidase. CA activity was also found to be significantly reduced. β-glucosidase and CA should be further investigated in terms of neurodegenerative disease risk factors, just like PON, whose importance has been determined by numerous studies in the literature.